DeutschNewstral
Article
jdsupra.com on 2018-10-10 21:38
New draft guidance proposes a shift in how the FDA will evaluate certain device modifications
Related news
- FDA Permits Quarterly Summary Reporting for Certain Medical Device Malfunctionsjdsupra.com
- FDA Issues Guidance Regarding Modifications to Certain Cleared Infusion Pumps During COVID-19 Public Health Emergencyjdsupra.com
- FDA Finalizes Program for Medical Device Reporting in Summary Form for Certain Manufacturersjdsupra.com
- FDA Draft Guidance and Pilot Program Seek to Expand Device Modifications Appropriate for the Special 510(k) Programjdsupra.com
- FDA Issues New Draft Guidance Requiring Modifications to Medical Device Tracking Labelsjdsupra.com
- FDA Inspires Modifications And Quick Authorizations For Ventilatorsjdsupra.com
- Medical Device Claims Sent to FTC, FDAjdsupra.com
- FDA Issues “PlayBook” for Medical Device Cybersecurityjdsupra.com
- FDA Releases Medical Device Cybersecurity Draft Guidancejdsupra.com
- FDA Announces Playbook for Medical Device Cybersecurityjdsupra.com
- FDA Final Guidance Document “Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry”jdsupra.com
- FinCEN exempts certain rollovers, renewals, modifications and extensions from beneficial ownership rulesjdsupra.com
- FDA Announces “Modernization” Reforms to Medical Device Review Processjdsupra.com
- FDA Tackles the Escalating Medical Device Cybersecurity Threatsjdsupra.com
- Evolution & Revolution: Device Policy Priorities at FDA in 2019jdsupra.com
- FDA FY 2021 Budget Foretells Medical Device Cybersecurity Reformjdsupra.com
- Medical Device Developments: FDA Finalizes Four 510(k) Guidance Documentsjdsupra.com
- FDA Withdraws Draft Guidance Regarding Statistical Approaches to Evaluate Analytical Similarity of Biosimilarsjdsupra.com
- FDA Reduces Regulatory Burden for Certain Medical Image Analyzersjdsupra.com
- Abbott Obtains FDA Approval for HeartMate 3 Devicejdsupra.com